Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 121 of 1,261
  1. US 11970523

    Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  2. US 11969470

    Topiramate compositions and methods of making and using the same

    Regents of the University of Minnesota · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  3. US 11969466

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  4. US 11969401

    Compositions and methods for treating or limiting development of age-related macular degeneration

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  5. US 11970479

    3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor

    MSD R&D (China) Co. Ltd. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  6. US 11969511

    Methods and compositions for antimicrobial treatment

    The Board of Regents of the University of Texas System · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  7. US 11969501

    Auris formulations for treating otic diseases and conditions

    The Regents of the University of California · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  8. US 11969408

    Method for improving mitophagy in subjects

    Amazentis SA · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  9. US 11969475

    Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

    Dyne Therapeutics, Inc. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  10. US 11969499

    Hydrogel delivery of sting immunotherapy for treatment cancer

    The Board of Regents of the University of Texas System · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  11. US 11970538

    Multispecific binding constructs against checkpoint molecules and uses thereof

    Compass Therapeutics LLC · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  12. US 2024131199

    PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Granted Apr 25, 2024 · Expires Apr 20, 2044

    granted
  13. US 11964019

    Cochleates made with soy phosphatidylserine

    MATINAS BIOPHARMA NANOTECHNOLOGIES, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  14. US 11965040

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  15. US 11965032

    Anti-CD20 antibody compositions

    TG Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  16. US 11963982

    CRISPR/RNA-guided nuclease systems and methods

    Editas Medicine, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  17. US 11964008

    Method for inactivating zika virus and for determining the completeness of inactivation

    Takeda Vaccines, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  18. US 11964989

    KRas G12D inhibitors

    Mirati Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  19. US 11965161

    Methods and compositions for sensitization of tumor cells to immune therapy

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  20. US 11965017

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  21. US 11963945

    Ozonides for treating or preventing virus infections

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  22. US 11964985

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  23. US 11964960

    Pyridinone- and pyridazinone-based compounds and uses thereof

    Tri-Institutional Therapeutics Discovery Institute, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  24. US 11964944

    Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases

    The Government of the United States · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.